Kayne Anderson Rudnick Investment Management
BMRN icon

Kayne Anderson Rudnick Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-44
Closed -$3K – 612
2022
Q1 		$3K Buy
+44
New +$3.68K ﹤0.01% 578
2021
Q1 		– Sell
-9
Closed -$1K – 582
2020
Q4 		$1K Buy
+9
New +$714 ﹤0.01% 582
2020
Q2 		– Sell
-1,000
Closed -$85K – 551
2020
Q1 		$85K Buy
+1,000
New +$86.2K ﹤0.01% 374
2018
Q2 		– Sell
-138,165
Closed -$11.2M – 340
2018
Q1 		$11.2M Sell
138,165
-66,811
-33% -$5.73M 0.08% 163
2017
Q4 		$18.3M Sell
204,976
-18,806
-8% -$1.64M 0.15% 132
2017
Q3 		$20.8M Sell
223,782
-4,095
-2% -$362K 0.19% 119
2017
Q2 		$20.7M Sell
227,877
-5,517
-2% -$502K 0.21% 119
2017
Q1 		$20.5M Sell
233,394
-3,888
-2% -$346K 0.22% 123
2016
Q4 		$19.7M Sell
237,282
-9,905
-4% -$852K 0.23% 118
2016
Q3 		$22.9M Buy
247,187
+70,048
+40% +$6.6M 0.29% 102
2016
Q2 		$13.8M Buy
177,139
+38,187
+27% +$3.25M 0.21% 133
2016
Q1 		$11.5M Buy
138,952
+38,414
+38% +$3.13M 0.19% 135
2015
Q4 		$10.5M Sell
100,538
-3,494
-3% -$365K 0.17% 137
2015
Q3 		$11M Buy
104,032
+1,068
+1% +$143K 0.19% 131
2015
Q2 		$14.1M Buy
+102,964
New +$12.8M 0.22% 126

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's BMRN Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2022, closing a stake of 44 shares — an estimated $3K sold.

Kayne Anderson Rudnick Investment Management first reported a position in BMRN in Q2 2015 and held it in 15 quarters. The position peaked at $22.9M in Q3 2016. 543 funds tracked by Wall St. Rank hold BMRN as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 44 BioMarin Pharmaceuticals shares in Q2 2022, an estimated $3K.
  • Kayne Anderson Rudnick Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2015 and held it in 15 quarters.
  • Kayne Anderson Rudnick Investment Management's BioMarin Pharmaceuticals position peaked at $22.9M in Q3 2016.
  • 543 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.